Concepedia

Émilie Chalayer

ÉC

Statistics

Publications

12

Citations

319

H-Index

11

Active since

2014

Affiliations

Centre Hospitalier Universitaire de Saint-Étienne(Current)

Inserm

Hospices Civils de Lyon

Hôpital Lyon Sud

Hôpital Saint-Louis

Émilie Chalayer is an author at Centre Hospitalier Universitaire de Saint-Étienne specializing in medicine, hematology, and multiple myeloma therapy.

ORCID

Publications per year

2014–2024

12

Publications

12

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Xavier Leleu, Cyrille Hulin, Jérôme Lambert et al. · Nature Medicine · 2024 · 107 citations · Full text

, , +17

Bone marrow involvement in systemic lupus erythematosus

Émilie Chalayer, N. Costedoat‐Chalumeau, Odile Beyne‐Rauzy et al. · QJM · 2017 · 37 citations · Full text

, , +13

Sarcoidosis and lymphoma: a comparative study

Émilie Chalayer, Emmanuel Bachy, Pauline Occelli et al. · QJM · 2015 · 36 citations · Full text

, , +13

Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group

Laurent Frenzel, Olivier Decaux, Margaret Macro et al. · Thrombosis Research · 2023 · 20 citations · Full text

, , +17

FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction

Juliette Tennenbaum, Matthieu Groh, Laura Venditti et al. · Stroke · 2021 · 18 citations · Full text

, , +16

1–5 of 12